TACC3 is essential for EGF-mediated EMT in cervical cancer

Geun-Hyoung Ha1, Jung-Lye Kim, Eun-Kyoung Breuer

  • 1Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.

Plos One
|August 13, 2013
PubMed

Insights

Transforming acidic coiled-coil protein 3 (TACC3) drives epithelial-mesenchymal transition (EMT) in cervical cancer. Targeting TACC3 may offer a new strategy for treating cancers driven by epidermal growth factor receptor (EGFR) signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Transforming acidic coiled-coil protein 3 (TACC3) is implicated in mitosis and deregulated in human cancers.
  • Previous research suggests TACC3's role in cervical cancer progression and chemoresistance, potentially inducing epithelial-mesenchymal transition (EMT) via PI3K/Akt and ERK pathways.
  • The upstream regulation and specific function of TACC3 in cervical cancer-associated EMT remain unclear.

Purpose of the Study:

  • To investigate the upstream mechanisms regulating TACC3 in cervical cancer.
  • To elucidate the role of TACC3 in epidermal growth factor (EGF)-induced EMT in cervical cancer.
  • To assess the functional and clinical significance of TACC3 in cervical cancer progression.

Main Methods:

  • Analyzed TACC3 expression in cervical cancer tissues.
  • Investigated TACC3 induction by EGF and its dependence on EGF receptor (EGFR) tyrosine kinase activity.
  • Utilized TACC3 depletion (e.g., siRNA) to assess its necessity in EGF-mediated EMT.
  • Examined the correlation between TACC3 and Snail expression in cervical cancer.

Main Results:

  • TACC3 is overexpressed in cervical cancer and its expression is induced by EGF in an EGFR-dependent manner.
  • Depletion of TACC3 abrogates EGF-induced EMT, establishing TACC3 as a requirement for this process.
  • TACC3 expression positively correlates with Snail, a key EMT regulator, in cervical cancer specimens.

Conclusions:

  • TACC3 plays a critical role in mediating EGF/EGFR-driven EMT in cervical cancer.
  • TACC3 is a novel functional component in the EGF-induced EMT pathway.
  • Targeting TACC3 presents a potential therapeutic strategy for cervical cancers associated with EGF/EGFR signaling.

Related Concept Videos

Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...